
According to WHO, there are a total of 155 new coronavirus vaccines under development worldwide, of which 23 have entered the clinical trial stage, at least 3 vaccines are currently in Phase 3 clinical trials, and at least 3 vaccines have completed phase 2 trials and are about to enter phase 3 (see the figure below for details).
Agency | Country | Progress |
Sinopharm/Wuhan Institute of Biological Products | China | Phase 3 |
Sinovac R&D | China | Phase 3 |
Oxford/AstraZeneca | UK | Phase 3 |
Sinopharm/Beijing Institute of Biological Products | China | Phase 2 |
Chinese Army's Medical Research Institute/CanSino Biologics | China | Phase 2 |
BioNTech/Pfizer | USA | Phase 2 |
Moderna | USA | Phase 2 |
A Phase 1 study typically studies a small number of people, normally 20-80 persons and focuses on whether a vaccine is safe and induces an immune response.
In Phase 2, the clinical study is expanded to several hundred persons and studies the safety, immunogenicity, recommended dosage, immunization schedule and methods of vaccination of candidate vaccinesA Phase 1 study typically studies a small number of people, normally 20-80 persons and focuses on whether a vaccine is safe and induces an immune response.
In Phase 3, the vaccine is given to thousands of people and the key goal is to evaluate the efficacy and again for safety.
The good news is all the above vaccines are now showing positive results.
The COVID-19 vaccine, as the most effective method to prevent infection with the COVID-19 virus, could be available by year end or early next year. But before getting vaccinated, keep social distancing, wear face mask and wash hands frequently can still be the best ways to protect the public from getting infected.
For government, finding (using rapid test kits) and tracking (using tracking app) could be much helpful in preventing the spread of COVID-19.

More information about Singclean IgG/IgM Test Kit, please find
-
singclean | 2020-07-29
Renowned International Medical Expert Prof. Osama Shawki Visits Singclean, Exploring New Global Collaboration in Anti-Adhesion SolutionsHangzhou, China — November 2, 2024 — Prof. Osama Shawki, a renowned international expert in obstetrics and gynecology, Professor at Cairo University, and globally recognized medical KOL with millions of views, visited the headquarters of Singclean Medical. -
singclean | 2020-07-29
A Powerful Alliance for Premium Aesthetics | Singclean Medical x HTL Biotechnology (France)On October 20, 2026, a four-member delegation from French HTL Biotechnology visited Singclean Medical for an exchange and factory tour. This significant meeting aimed to deepen the strategic cooperation between the two parties in the application of premium hyaluronic acid (HA) raw materials and global brand promotion, jointly exploring new growth opportunities for premium injectable HA in the global market. -
singclean | 2020-07-29
Singclean Medical: 15 Years of Chongyang Care — 2026 Event Reaches 337 Elderly Residents Across 6 CommunitiesIn 2011, during the Chongyang Festival—a traditional Chinese occasion dedicated to respecting the elderly—Singclean Medical first entered local communities to deliver cooking oil, rice, and other daily necessities to senior residents. That simple act of care has never stopped. For 15 consecutive years, the company has continued this tradition, bringing warmth and support to the elderly every autumn.